[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Lezaic L, Erba PA, Decristoforo C, Zaletel K, Mikolajczak R, Maecke H, Maina T, Konijnenberg M, Kolenc P, Trofimiuk-Müldner M, Przybylik-Mazurek E, Virgolini I, de Jong M, Fröberg AC, Rangger C, Di Santo G, Skorkiewicz K, Garnuszek P, Solnica B, Nock BA, Fedak D, Gaweda P, Hubalewska-Dydejczyk A.
Lezaic L, et al. Among authors: froberg ac.
Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):892-907. doi: 10.1007/s00259-022-05992-6. Epub 2022 Nov 5.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36334104
Free PMC article.
Clinical Trial.